Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer
Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate if giving bevacizumab prior to chemotherapy compared
to giving bevacizumab at the same time as chemotherapy improves patient overall response to
treatment.